1300017I duke university; vteu; task B1C1; biod can 8470038; $50,915

Ended Awarded Last action

Contract number
HHSN27200004
Awardee
Awarding agency
Obligated
$1,154,053

Award facts

Opportunity
Contract value 100% obligated
$1,154,053.22 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 2 offers Multiple Award, Fair Opportunity
Pricing
Cost No Fee
Place of performance
Durham, NC 27705, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00011 $13,162
Other Administrative Action P00010 $0
Funding Only Action P00009 -$194,778
Supplemental Agreement for work within scope P00008 $0
Supplemental Agreement for work within scope P00007 $0
Supplemental Agreement for work within scope P00006 $0
Supplemental Agreement for work within scope P00005 $489,532
Supplemental Agreement for work within scope P00004 · A phase i, single dose, open-label, parallel group study comparing the pharmacokinetics and safety of PA-824 in subjects with mild, moderate and severe… $0
Other Administrative Action 3 · To extend the period of performance of option 1, line item 2, from april 1, 2015 through february 1, 2017, to april 1, 2015 through february 1, 2019. $0
Exercise an Option 2 · Modification to exercise option 1 for protocol implementation. $795,222
Other Administrative Action 1 · Modification to extend the POP on the base to 31MAY2015. $0
Original award $50,915
Show all 12

About this award

Written by GovTribe AI ·

This is a federal contract award to Duke University, a private university, by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH). The contract is part of the Vaccine and Treatment Evaluation Units (VTEU) program, which supports clinical research on vaccines and treatments for infectious diseases.

The specific award is for Task B1C1 under contract HHSN272201300017I, with a ceiling value of $1,154,053.22. The award date was September 9, 2014, and the ultimate completion date is March 31, 2025. The contract does not have a set-aside designation. Duke University's Office of Research Administration Division is the prime contractor for this award.

The award provides funding for Duke University to conduct biomedical research and development services related to the VTEU program. The specific services to be provided are not detailed, but are likely to include clinical trials, vaccine and treatment evaluation, and other infectious disease research activities.

Quick answers

Who was awarded contract HHSN27200004?

HHSN27200004 was awarded to Duke University by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 9, 2014.

How much is contract HHSN27200004 worth?

The government has obligated $1,154,053 on HHSN27200004.

Is contract HHSN27200004 an order under another contract?

Yes. HHSN27200004 is a delivery order under HHSN272201300017I, an indefinite delivery contract, on Vaccine and Treatment Evaluation Units (VTEU).

Was contract HHSN27200004 competed?

The extent of competition for HHSN27200004 was full and open competition. The government received 2 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login